Total Payments
$5,612
2024 Payments
$448.65
Companies
36
Transactions
323
Medicare Patients
5,291
Medicare Billing
$448,912
Payment Breakdown by Category
Food & Beverage$5,546 (98.8%)
Education$65.88 (1.2%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $5,546 | 321 | 98.8% |
| Education | $65.88 | 2 | 1.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novo Nordisk Inc | $1,765 | 93 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $758.63 | 35 | $0 (2024) |
| Lilly USA, LLC | $489.39 | 34 | $0 (2024) |
| ABBVIE INC. | $389.08 | 37 | $0 (2023) |
| Janssen Pharmaceuticals, Inc | $329.58 | 15 | $0 (2022) |
| Amgen Inc. | $310.62 | 15 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $302.52 | 16 | $0 (2024) |
| PFIZER INC. | $234.65 | 15 | $0 (2024) |
| Abbott Laboratories | $216.71 | 12 | $0 (2024) |
| Merck Sharp & Dohme Corporation | $110.47 | 9 | $0 (2021) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $448.65 | 27 | Novo Nordisk Inc ($174.96) |
| 2023 | $798.49 | 45 | Novo Nordisk Inc ($312.68) |
| 2022 | $928.48 | 66 | Novo Nordisk Inc ($257.99) |
| 2021 | $1,213 | 78 | Novo Nordisk Inc ($328.46) |
| 2020 | $588.10 | 34 | Novo Nordisk Inc ($183.49) |
| 2019 | $868.50 | 45 | Novo Nordisk Inc ($321.37) |
| 2018 | $766.61 | 28 | AstraZeneca Pharmaceuticals LP ($335.86) |
All Payment Transactions
323 individual payment records from CMS Open Payments — Page 1 of 13
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/19/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $13.64 | General |
| Category: Gastroenterology | ||||||
| 11/18/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $15.76 | General |
| Category: Diabetes | ||||||
| 09/30/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $13.38 | General |
| Category: Diabetes | ||||||
| 09/23/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $18.79 | General |
| Category: Obesity | ||||||
| 09/17/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $15.04 | General |
| Category: PAIN | ||||||
| 08/26/2024 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $18.85 | General |
| 08/19/2024 | PFIZER INC. | PREVNAR 20 (Biological), COMIRNATY, ABRYSVO | Food and Beverage | In-kind items and services | $14.94 | General |
| Category: VACCINES | ||||||
| 08/15/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $18.43 | General |
| Category: Obesity | ||||||
| 08/05/2024 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $24.24 | General |
| Category: Diabetes Care | ||||||
| 06/26/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $14.88 | General |
| Category: Diabetes | ||||||
| 06/13/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $17.44 | General |
| Category: Diabetes | ||||||
| 05/23/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $17.02 | General |
| Category: Diabetes | ||||||
| 05/02/2024 | Dexcom, Inc. | Dexcom G6 Transmitter (Medical Supply) | Food and Beverage | In-kind items and services | $21.24 | General |
| Category: Endocrinology | ||||||
| 04/25/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $16.73 | General |
| Category: Diabetes | ||||||
| 04/10/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $15.12 | General |
| Category: PAIN | ||||||
| 03/21/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $16.77 | General |
| Category: Diabetes | ||||||
| 03/13/2024 | Lilly USA, LLC | JARDIANCE (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $14.87 | General |
| Category: Diabetes | ||||||
| 03/07/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $17.47 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 02/22/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $16.45 | General |
| Category: Diabetes | ||||||
| 02/19/2024 | PFIZER INC. | PREVNAR 20 (Biological), COMIRNATY, ABRYSVO | Food and Beverage | In-kind items and services | $14.47 | General |
| Category: VACCINES | ||||||
| 02/07/2024 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $17.26 | General |
| 01/31/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $16.45 | General |
| Category: Inflammation | ||||||
| 01/30/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $16.90 | General |
| Category: Respiratory | ||||||
| 01/25/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $17.22 | General |
| Category: Diabetes | ||||||
| 01/19/2024 | Lilly USA, LLC | TRULICITY (Drug), MOUNJARO | Food and Beverage | In-kind items and services | $14.73 | General |
| Category: Diabetes | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 24 | 1,639 | 3,151 | $295,884 | $146,582 |
| 2022 | 22 | 1,223 | 2,203 | $227,148 | $81,751 |
| 2021 | 25 | 1,272 | 2,124 | $239,862 | $123,758 |
| 2020 | 20 | 1,157 | 2,188 | $225,599 | $96,821 |
Total Patients
5,291
Total Services
9,666
Medicare Billing
$448,912
Procedure Codes
91
All Medicare Procedures & Services
91 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 378 | 861 | $142,065 | $66,314 | 46.7% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 151 | 151 | $24,462 | $17,865 | 73.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 214 | 290 | $32,770 | $16,026 | 48.9% |
| 99497 | Advance care planning, first 30 minutes | Office | 2023 | 137 | 137 | $17,125 | $10,412 | 60.8% |
| 99308 | Subsequent nursing facility care with straightforward level of medical decision making, per day, if using time, at least 15 minutes | Office | 2023 | 32 | 102 | $9,996 | $4,863 | 48.6% |
| 99309 | Subsequent nursing facility care with moderate level of medical decision making, per day, if using time, at least 30 minutes | Office | 2023 | 24 | 67 | $8,710 | $4,835 | 55.5% |
| 90677 | Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | Office | 2023 | 14 | 14 | $4,270 | $3,960 | 92.8% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2023 | 54 | 54 | $5,400 | $3,884 | 71.9% |
| 87428 | Detection test by immunoassay technique for severe acute respiratory syndrome coronavirus and influenza | Office | 2023 | 45 | 49 | $8,575 | $2,640 | 30.8% |
| 99495 | Transitional care management services for problem of at least moderate complexity | Office | 2023 | 17 | 17 | $3,961 | $2,561 | 64.7% |
| J1040 | Injection, methylprednisolone acetate, 80 mg | Office | 2023 | 56 | 256 | $5,120 | $2,166 | 42.3% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 20 | 20 | $4,660 | $1,835 | 39.4% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 75 | 75 | $1,875 | $1,813 | 96.7% |
| 83036 | Hemoglobin a1c level | Office | 2023 | 89 | 193 | $8,492 | $1,790 | 21.1% |
| 99305 | Initial nursing facility care with moderate level of medical decision making, per day, if using time, at least 35 minutes | Office | 2023 | 17 | 18 | $3,366 | $1,446 | 43.0% |
| 90694 | Influenza vaccine, quadrivalent inactivated, 0.5 ml dosage | Office | 2023 | 19 | 19 | $1,900 | $1,440 | 75.8% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 89 | 121 | $5,445 | $1,140 | 20.9% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 11 | 11 | $1,672 | $559.43 | 33.5% |
| G0009 | Administration of pneumococcal vaccine | Office | 2023 | 14 | 14 | $350.00 | $343.00 | 98.0% |
| 81002 | Urinalysis, manual test | Office | 2023 | 71 | 96 | $1,536 | $327.36 | 21.3% |
| 99406 | Smoking and tobacco use intensive counseling, 4-10 minutes | Office | 2023 | 12 | 12 | $252.00 | $165.60 | 65.7% |
| 82044 | Urine microalbumin (protein) analysis | Office | 2023 | 20 | 20 | $960.00 | $116.09 | 12.1% |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | Office | 2023 | 30 | 106 | $1,802 | $40.81 | 2.3% |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | Office | 2023 | 50 | 448 | $1,120 | $39.08 | 3.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 277 | 692 | $114,180 | $35,362 | 31.0% |
About Dr. Daniel Holdman, MD
Dr. Daniel Holdman, MD is a Family Medicine healthcare provider based in Bartlesville, Oklahoma. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/18/2008. The National Provider Identifier (NPI) number assigned to this provider is 1972768919.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Daniel Holdman, MD has received a total of $5,612 in payments from pharmaceutical and medical device companies, with $448.65 received in 2024. These payments were reported across 323 transactions from 36 companies. The most common payment nature is "Food and Beverage" ($5,546).
As a Medicare-enrolled provider, Holdman has provided services to 5,291 Medicare beneficiaries, totaling 9,666 services with total Medicare billing of $448,912. Data is available for 4 years (2020–2023), covering 91 distinct procedure/service records.
Ad
Practice Information
- Specialty Family Medicine
- Location Bartlesville, OK
- Active Since 07/18/2008
- Last Updated 10/19/2018
- Taxonomy Code 207Q00000X
- Entity Type Individual
- NPI Number 1972768919
Products in Payments
- Ozempic (Drug) $940.10
- FARXIGA (Drug) $541.46
- XARELTO (Drug) $329.58
- JARDIANCE (Drug) $319.27
- Rybelsus (Drug) $275.00
- TRULICITY (Drug) $190.39
- RYBELSUS (Drug) $180.05
- QULIPTA (Drug) $176.60
- UBRELVY (Drug) $158.78
- Wegovy (Drug) $139.39
- SYMBICORT (Drug) $127.51
- Otezla (Drug) $123.31
- MOUNJARO (Drug) $112.16
- VRAYLAR (Drug) $106.95
- Repatha (Biological) $105.25
- NURTEC ODT (Drug) $98.42
- FREESTYLE LIBRE 3 (Device) $91.14
- FREESTYLE LIBRE 2 (Device) $87.83
- EMGALITY (Drug) $76.36
- Saxenda (Drug) $67.47
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Bartlesville
Mark Erhardt, D.o, D.O
Family Medicine — Payments: $7,806
Family Medicine $7,806
Elizabeth Sherrock, M.d, M.D
Family Medicine — Payments: $6,925
Family Medicine $6,925
William Davito, D.o, D.O
Family Medicine — Payments: $4,991
Family Medicine $4,991
Michael Vaclaw, M.d, M.D
Family Medicine — Payments: $4,027
Family Medicine $4,027
Ashley Estep, Do, DO
Family Medicine — Payments: $3,276
Family Medicine $3,276
Gerald Pribil, Md, MD
Family Medicine — Payments: $2,266
Family Medicine $2,266